Bylvay™
Bylvay is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC).
Frontier Therapies II - Optum
6425 Santa Margarita St. #110
Las Vegas, NV 89118
NABP: 788638
NPI: 1720364532
NCPDP: 2992750
Send the appropriate therapy forms and documentation to 1-866-991-9929.
Discuss the process, understand how to submit documentation, or place an order by calling us at 1-855-768-9727.
Find out more about the therapies we dispense below. Select Find forms to access the appropriate therapy enrollment forms and documentation.
Bylvay is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC).
NITYR® is a hydroxyphenyl-pyruvate dioxygenase inhibitor used to treat adults and children with hereditary tyrosinemia type 1 (HT-1). NITYR works by preventing the body from breaking down an amino acid called tyrosine and by keeping other toxic substances from building up and causing harm to liver or kidneys.
Sajazir is an injectable form of icatibant, a bradykinin B2 receptor antagonist, that treats swelling from Hereditary Angiodema (HAE) in patients 18 years and older.
Sucraid® is an enzyme replacement therapy for the treatment of genetically determined sucrase deficiency, which is part of Congenital Sucrase-Isomaltase Deficiency (CSID).
VOXZOGO™ is a C type natriuretic peptide (CNP) analog indicated to increase linear growth in pediatric patients with achondroplasia who are 5 years of age and older with open epiphyses.